Targeting the fetal acetylcholine receptor in rhabdomyosarcoma

Author： Simon-Keller Katja Barth Stefan Vincent Angela Marx Alexander

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.2, 2013-03, pp. : 127-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel insights into muscarinic acetylcholine receptor function using gene targeting technology

By Wess J.

Trends in Pharmacological Sciences, Vol. 24, Iss. 8, 2003-08 ,pp. : 414-420

Elsevier

Access to resources Recommend Favorite

Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome

Current Drug Targets, Vol. 13, Iss. 1, 2012-01 ,pp. : 53-71

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Apoptosis Resistance in Rhabdomyosarcoma

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-01 ,pp. : 536-544

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of the nicotinic acetylcholine receptor from fetal rat muscle expressed in Xenopus oocytes

By Cooper J.C. Gutbrod O. Witzemann V. Methfessel C.

European Journal of Pharmacology, Vol. 309, Iss. 3, 1996-08 ,pp. : 287-298

Elsevier

Access to resources Recommend Favorite

Targeting the α₉α₁₀ nicotinic acetylcholine receptor to treat severe pain

By Vincler Michelle McIntosh J Michael

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 891-897

Informa Healthcare

Access to resources Recommend Favorite